On October 21, 2022, MedX Health Corp closed the transaction. The company issued 10 Series III Notes for CAD 500,000 in its third and final tranche closing. The tranche included participation from returning investor Forest Lane Holdings Limited for CAD 500,000.

The company issued a total of 22 Series III Note for total gross proceeds of CAD 1,100,000 in the transaction. The notes will mature on December 31, 2026. In accordance with relevant regulatory and stock exchange policies, the securities issued in connection with the Series III Notes are restricted from trading for a period of four months from the original issue dates of the Series III Notes.

The transaction has been aprproved by the TSX Venture Exchange.